On August 10, XTALPI rose 7.28% in regular trading, reaching HKD 8.11, with turnover of HKD 61.80 million. The rally was driven by the company's formal launch of its XtalPi Science platform and the formation of a Scientific Intelligence Open Ecosystem Alliance with 26 partner institutions.

The platform release has triggered market expectations for a valuation logic shift from a traditional CRO service provider to an AI platform company. Under the alliance framework, members gain access to platform resources, automation lab capabilities, model integration, and co-development opportunities. Additionally, the company's board will convene on August 19 to review interim results for the six months ended June 30, with the approaching earnings window drawing incremental capital attention.

At the sector level, Life Sciences Tools and Services stocks showed broad strength, with INSILICO up 10.26%, GENSCRIPT BIO up 5.31%, WUXI APPTEC up 4.32%, WUXI BIO up 3.84%, and PHARMARON up 1.67%, reflecting notable capital resonance across the AI drug discovery space.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)